Prognostic factors in uveal melanoma

Melanoma Research

Volumn 11, Issue 3, 2001, Pages 255-263

  Singh, A D ^a   Shields, C L ^a   Shields, J A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Melanoma; Prognostic factors; Survival; Uveal neoplasms

Indexed keywords

CYCLINE; HISTOCOMPATIBILITY ANTIGEN; KI 67 ANTIGEN;

ANEUPLOIDY; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CELL TYPE; CHROMOSOME NOR; CYTOGENETICS; CYTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROCIRCULATION; MITOSIS; MOLECULAR GENETICS; PRIORITY JOURNAL; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR LOCALIZATION; TUMOR VOLUME; UVEA MELANOMA;

CELL DIVISION; DISEASE PROGRESSION; HUMANS; MELANOMA; PROGNOSIS; TIME FACTORS; UVEAL NEOPLASMS;

EID: 0034955640     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200106000-00007     Document Type: Article

References (75)

1. Melanomas of the eye: Stability of rates
2. Management of posterior uveal melanoma
3. The differential diagnosis of posterior uveal melanoma
4. Metastatic uveal melanoma. Hepatic metastasis identified by hybridoma-secreted monoclonal antibody Mab8-1H
5. Screening for metastatic malignant melanoma of the uvea revisited
6. Risk factors for growth and metastasis of small choroidal melanocytic lesions
7. Transpupillary thermotherapy in choroidal melanomas
8. Transpupillary thermotherapy for choroidal melanoma. Tumor control and visual results in 100 consecutive cases
9. Malignant melanomas of the human uvea. Recent follow up of cases in Denmark, 1943-1952
10. Iris melanoma: Risk factors in 169 consecutive cases
11. The prognosis of primary tumors of iris treated by iridectomy
12. The melanoma controversy. A comparison of choroidal, cutaneous, and iris melanomas
13. Melanoma of the iris: Report of 72 cases treated surgically
14. Malignant melanoma of the iris. A 25-year analysis of Danish cases
15. Uveal melanoma: Location, size, cell type, and enucleation as risk factors in metastasis
16. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma
17. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement
18. Prognostic factors in small malignant melanomas of choroid and ciliary body
19. Prognostic factors in choroidal and ciliary body melanomas
20. Malignant melanomas of the human uvea in Denmark, 1943-1952
21. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988
22. Mortality in patients with small choroidal melanoma. COMS report no. 4
23. Diffuse choroidal melanoma: Clinical features predictive of metastasis
24. Diffuse malignant melanoma of the uveal tract: A clinicopathologic report of 54 cases
25. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells?
26. An evaluation of enucleation in the management of uveal melanomas
27. Survival rates after enucleation of eyes with malignant melanoma
28. Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: Comparison of survival by prognostic index groups
29. Relative survival rates after alternative therapies for uveal melanoma
30. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma
31. Enucleation versus plaque irradiation for choroidal melanoma
32. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: Initial mortality findings. COMS report no. 10
33. Prognosis of malignant melanomas of the choroid and ciliary body
34. A comparison of prognostic covariates for uveal melanoma
35. Malignant melanotic tumors of the eye. A study of histologic types in 111 cases
36. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology
37. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors
38. Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas
39. The prognostic value of tumor blood vessel morphology in primary uveal melanoma
40. Analysis of lymphocytic infiltration in uveal melanoma
41. HLA expression and tumor-infiltrating immune cells in uveal melanoma
42. Lymphocytic infiltration in uveal malignant melanoma
43. Histopathologic characteristics of uveal melanoma in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6
44. The value of nucleolar organizer regions in uveal melanoma
45. DNA content abnormalities and prognosis in uveal melanoma
46. An immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma
47. Prognostic parameters in uveal melanoma: A review
48. Ki-67 immunostaining in uveal melanoma; the effect of preenucleation radiotherapy
49. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma
50. PC-10 as predictor of prognosis after antigen retrieval in posterior uveal melanoma
51. Expression of HLA antigens in paraffin sections of uveal melanomas
52. Cytogenetic findings in primary uveal melanoma
53. Correlation of cytogenetic abnormalities with outcome of patients with uveal melanoma
54. Cytogenetic analysis of uveal melanoma: Consistent occurrence of monosomy 3 and trisomy 8q
55. Prognostic implications of monosomy 3 in uveal melanoma
56. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis
57. C-myc oncogene expression in ocular melanomas
58. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma
59. Genetic aspects of uveal melanoma: A brief review
60. No N-ras mutation in human uveal melanoma: The role of ultraviolet light revisited
61. Increased expression and mutation of p53 in choroidal melanoma
62. p53 gene and cell cycling in uveal melanoma
63. Germline brca2 sequence variants in patients with ocular melanoma
64. A cell regulator potentially involved in genesis of many tumor types
65. Deletion of the cyclin dependent kinase-inhibitor gene in multiple human cancers
66. Rarity of somatic and germline mutations of the cyclin dependent kinase-4 inhibitor gene in melanoma
67. Familial uveal melanoma: Absence of germline mutations involving the cyclin dependent kinase-4 inhibitor (p16) gene in uveal melanoma
68. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma
69. Thickness, cross sectional areas and depth of melanoma in the prognosis of cutaneous melanoma
70. Individualized prognosis for melanoma patients
71. A multifactorial analysis of melanoma IV. Prognostic factors in 200 melanoma patients with distant metastasis (stage III)
72. Treatment of metastatic uveal melanoma: Review and recommendations
73. Treatment of uveal melanoma metastatic to the liver: A review of the MD Anderson Cancer Center experience and prognostic factors
74. Management of uveal melanoma: A continuing dilemma